1/14
08:21 pm
ew
Edwards Lifesciences (EW) Valuation Check As Recent Share Momentum Meets Premium P/E Pricing [Yahoo! Finance]
Low
Report
Edwards Lifesciences (EW) Valuation Check As Recent Share Momentum Meets Premium P/E Pricing [Yahoo! Finance]
1/13
06:33 am
ew
Edwards calls off JenaValve buyout after court halts deal [Yahoo! Finance]
Low
Report
Edwards calls off JenaValve buyout after court halts deal [Yahoo! Finance]
1/12
10:58 am
ew
Edwards Lifesciences (NYSE:EW) had its "neutral" rating reaffirmed by analysts at UBS Group AG.
Low
Report
Edwards Lifesciences (NYSE:EW) had its "neutral" rating reaffirmed by analysts at UBS Group AG.
1/12
10:58 am
ew
Edwards Lifesciences (NYSE:EW) was given a new $90.00 price target on by analysts at Robert W. Baird.
Low
Report
Edwards Lifesciences (NYSE:EW) was given a new $90.00 price target on by analysts at Robert W. Baird.
1/12
08:42 am
ew
Edwards Lifesciences (NYSE:EW) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
Medium
Report
Edwards Lifesciences (NYSE:EW) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
1/9
07:03 pm
ew
Edwards Comments on JenaValve Acquisition [Yahoo! Finance]
Low
Report
Edwards Comments on JenaValve Acquisition [Yahoo! Finance]
1/9
06:48 pm
ew
Edwards Comments on JenaValve Acquisition
Low
Report
Edwards Comments on JenaValve Acquisition
1/9
08:42 am
ew
Edwards Lifesciences (NYSE:EW) was upgraded by analysts at TD Cowen from a "hold" rating to a "buy" rating. They now have a $97.00 price target on the stock.
Low
Report
Edwards Lifesciences (NYSE:EW) was upgraded by analysts at TD Cowen from a "hold" rating to a "buy" rating. They now have a $97.00 price target on the stock.
1/9
07:00 am
ew
Edwards Lifesciences (NYSE:EW) was upgraded by analysts at Cowen Inc from a "hold" rating to a "buy" rating.
Low
Report
Edwards Lifesciences (NYSE:EW) was upgraded by analysts at Cowen Inc from a "hold" rating to a "buy" rating.
1/9
07:00 am
ew
Edwards Lifesciences (NYSE:EW) had its "buy" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
Low
Report
Edwards Lifesciences (NYSE:EW) had its "buy" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
1/8
06:17 am
ew
Investing in Edwards Lifesciences (NYSE:EW) a year ago would have delivered you a 14% gain [Yahoo! Finance]
Low
Report
Investing in Edwards Lifesciences (NYSE:EW) a year ago would have delivered you a 14% gain [Yahoo! Finance]
1/7
09:24 am
ew
Edwards Lifesciences (NYSE:EW) had its price target raised by analysts at Stifel Nicolaus from $100.00 to $105.00. They now have a "buy" rating on the stock.
Low
Report
Edwards Lifesciences (NYSE:EW) had its price target raised by analysts at Stifel Nicolaus from $100.00 to $105.00. They now have a "buy" rating on the stock.
1/5
10:58 am
ew
Edwards Lifesciences (NYSE:EW) had its "outperform" rating reaffirmed by analysts at Evercore ISI.
Low
Report
Edwards Lifesciences (NYSE:EW) had its "outperform" rating reaffirmed by analysts at Evercore ISI.
12/29
05:32 pm
ew
The Edwards Lifesciences Dilemma Persists: Strong Growth Potential, High Price [Seeking Alpha]
Low
Report
The Edwards Lifesciences Dilemma Persists: Strong Growth Potential, High Price [Seeking Alpha]
12/24
12:45 pm
ew
HALPER SADEH LLC ENCOURAGES EDWARDS LIFESCIENCES CORPORATION SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
Low
Report
HALPER SADEH LLC ENCOURAGES EDWARDS LIFESCIENCES CORPORATION SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
12/24
12:37 am
ew
Edwards Lifesciences (EW): Assessing Valuation After Recent Share Price Strength [Yahoo! Finance]
Low
Report
Edwards Lifesciences (EW): Assessing Valuation After Recent Share Price Strength [Yahoo! Finance]
12/23
09:00 am
ew
FDA Approves Edwards Lifesciences' SAPIEN M3 Mitral Valve Replacement System as First Transseptal Transcatheter Therapy
Low
Report
FDA Approves Edwards Lifesciences' SAPIEN M3 Mitral Valve Replacement System as First Transseptal Transcatheter Therapy
12/22
01:02 pm
ew
4 Large-Cap MedTech Stocks to Keep Winning Streaks Alive in 2026 [Yahoo! Finance]
Low
Report
4 Large-Cap MedTech Stocks to Keep Winning Streaks Alive in 2026 [Yahoo! Finance]
12/18
09:34 am
ew
Relief Cardiovascular Appoints Harry Rowland as Chairman of the Board [Yahoo! Finance]
Low
Report
Relief Cardiovascular Appoints Harry Rowland as Chairman of the Board [Yahoo! Finance]
12/18
08:43 am
ew
Edwards Lifesciences (NYSE:EW) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $100.00 price target on the stock, up previously from $90.00.
Low
Report
Edwards Lifesciences (NYSE:EW) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $100.00 price target on the stock, up previously from $90.00.
12/18
07:10 am
ew
Edwards Lifesciences (NYSE:EW) was given a new $100.00 price target on by analysts at Wells Fargo & Company.
Low
Report
Edwards Lifesciences (NYSE:EW) was given a new $100.00 price target on by analysts at Wells Fargo & Company.
12/18
07:05 am
ew
Edwards Lifesciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
Low
Report
Edwards Lifesciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
12/17
10:38 am
ew
Transcatheter Heart Valve Replacement Market Size to Reach USD 19.98 Billion by 2033, Growing at a CAGR of 15.32% – SNS Insider [Yahoo! Finance]
Low
Report
Transcatheter Heart Valve Replacement Market Size to Reach USD 19.98 Billion by 2033, Growing at a CAGR of 15.32% – SNS Insider [Yahoo! Finance]
12/17
10:05 am
ew
Edwards Lifesciences (NYSE:EW) was given a new $87.00 price target on by analysts at Canaccord Genuity Group Inc..
Low
Report
Edwards Lifesciences (NYSE:EW) was given a new $87.00 price target on by analysts at Canaccord Genuity Group Inc..
12/16
07:08 am
ew
Edwards Lifesciences (NYSE:EW) was given a new $87.00 price target on by analysts at Robert W. Baird.
Low
Report
Edwards Lifesciences (NYSE:EW) was given a new $87.00 price target on by analysts at Robert W. Baird.